Package 72516-024-25

Brand: papaverine hydrochloride

Generic: papaverine hydrochloride
NDC Package

Package Facts

Identity

Package NDC 72516-024-25
Digits Only 7251602425
Product NDC 72516-024
Description

25 VIAL in 1 CARTON (72516-024-25) / 2 mL in 1 VIAL

Marketing

Marketing Status
Marketed Since 2021-02-01
Brand papaverine hydrochloride
Generic papaverine hydrochloride
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "2b4bd8c6-2b93-d435-e063-6394a90ae742", "openfda": {"unii": ["23473EC6BQ"], "rxcui": ["1789947"], "spl_set_id": ["5ba6e650-a5b5-4381-a62a-b7a6df73e8e6"], "manufacturer_name": ["Oryza Pharmaceuticals Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 VIAL in 1 CARTON (72516-024-10)  / 2 mL in 1 VIAL", "package_ndc": "72516-024-10", "marketing_start_date": "20210201"}, {"sample": false, "description": "25 VIAL in 1 CARTON (72516-024-25)  / 2 mL in 1 VIAL", "package_ndc": "72516-024-25", "marketing_start_date": "20210201"}], "brand_name": "Papaverine Hydrochloride", "product_id": "72516-024_2b4bd8c6-2b93-d435-e063-6394a90ae742", "dosage_form": "INJECTION, SOLUTION", "product_ndc": "72516-024", "generic_name": "Papaverine Hydrochloride", "labeler_name": "Oryza Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Papaverine Hydrochloride", "active_ingredients": [{"name": "PAPAVERINE HYDROCHLORIDE", "strength": "30 mg/mL"}], "marketing_category": "UNAPPROVED DRUG OTHER", "marketing_start_date": "20210201", "listing_expiration_date": "20261231"}